JCB, Volume 10, Number 3, 2004 Editorial Vol.10 No. 3 (2004) Editorial Derek Burke   Article Vol.10 No. 3 (2004) Public-good plant breeding: What should be done next? Philip J Dale Plant breeding has played a major role in improving crop production during the past century. From the birth of genetics to the early 1980s plant breeding was driven in Article Vol.10 No. 3 (2004) Commercial plant breeding: What is in the biotech pipeline? Andrew Cockbum Of all of humankind's endeavours, agriculture has led to the most pressure on land, its resources and biodiversity. Over the past 50 years, the need to increase food pr Article Vol.10 No. 3 (2004) The field-scale evaluation of herbicide-tolerant genetically modified crops conducted in the UK (1998–2003) Roger Turner In 1998 the UK Government, in conjunction with Supply Chain Initiative on Modified Agricultural Crops (SCIMAC, a cross-industry group representing the supply chain), es Article Vol.10 No. 3 (2004) Genetically modified crops: Broader environmental issues Alan Gray Looking back over the five years since a similar review of the field, this paper considers some of the research designed to address those uncertainties that, in part, l Article Vol.10 No. 3 (2004) Recent developments in the regulatory system in the UK Janet M Bainbridge Regulatory frameworks are the mechanisms to ensure that both genetically modified (GM) crops, which are to be released into the environment, and GM foods and feeds, whi Article Vol.10 No. 3 (2004) The regulatory system in the EU and further afield Julian Kinderlerer The regulation of modern biotechnology began almost as soon as the potential benefits and risks became clear. In some countries a decision was made to use current law t Article Vol.10 No. 3 (2004) Seeds, food and trade wars: Public opinion and policy responses in the USA and Europe Toby A Ten Eyck The political debate over genetically modified foods entered a new phase when the USA (under the Bush Administration) threatened legal actions within the World Trade Or Article Vol.10 No. 3 (2004) Interview: The current and future status of GM technology Alex K Pavlou Interview with Dr Sandy Thomas, Director of the Nuffield Council on Bioethics Article Vol.10 No. 3 (2004) Marketspace: The immunotherapies markets, 2003–2008 Alex K Pavlou Analysis of 170 leading and emerging therapeutic antibodies (Ab) and vaccine companies unveils two different business growth trends. The therapeutic antibodies sector w Article Vol.10 No. 3 (2004) Legal and regulatory update John Wilkinson Article 81(1) of the Treaty of Rome prohibits all agreements, decisions and concerted practices that may affect trade between member states and that have as their objec Book Review Vol.10 No. 3 (2004) Book Review: Clinica Reports: The Complete Guide to the Diagnostics Market 2004–2009 Anthony Stevens Clinica Reports: The Complete Guide to the Diagnostics Market 2004–2009 M Simonsen PJB Publication, Richmond; 2003; 262pp; £1300
